Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Article Type
Date
Availability
1-2 of 2
Keywords: proprotein convertase subtilisin/kexin type 9
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9
Available to Purchase
Journal:
Clinical Science
Clin Sci (Lond) (2015) 129 (1): 63–79.
Published: 15 April 2015
... lipoprotein-cholesterol proprotein convertase subtilisin/kexin type 9 The causal relationship between hypercholesterolaemia resulting from elevation in plasma concentrations of low-density lipoprotein (LDL) and the development of atherosclerosis and coronary artery disease (CAD) is well attested...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2015) 128 (6): 379–385.
Published: 02 December 2014
...Dick C. Chan; Annette T. Y. Wong; Jing Pang; P. Hugh R. Barrett; Gerald F. Watts Postprandial lipaemia, due to elevated plasma apolipoprotein (apo) B-48 concentrations, contributes to increased cardiovascular (CV) risk in obesity. Proprotein convertase subtilisin/kexin type 9 (PCSK9) and apoC-III...